Everyday Health7d
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval
Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...
EBGLYSS for eczema: What to know about the newly FDA-approved drug from Eli Lilly
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
ophthalmologytimes2d
Study finds a pair of common surgeries equally effective for treating blinding condition of the eyelid
The study, funded by the National Institutes of Health, supports no change to surgical technique for trichiasis management.
FDA Approves New Biologic Treatment For Atopic Dermatitis, Know How It Can Help Achieve Clear Skin
The FDA has approved Ebglyss (lebrikizumab-lbkz), a new biologic treatment for moderate-to-severe atopic dermatitis in people ...
Medscape11d
FDA Approves Lebrikizumab for Atopic Dermatitis
The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...
Medpage Today on MSN11d
Lebrikizumab Wins FDA Approval for Eczema
The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...
Hosted on MSN11mon
Eye Pain or Irritation: 10 Common Causes and How to Treat
If the pain doesn't resolve with at-home treatment, gets worse or is accompanied by vision ... that can result from infection include blepharitis, which affects the eyelids, and keratitis, which ...
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab ...
The Financial7d
Two common surgeries equally effective for treating blinding condition of the eyelid
">On a normal eyelid (left), eyelashes are turned outward away from the cornea. Eyelids affected by trichiasis (center) have ...
Daily11d
FDA Approves lebrikizumab for treatment of atopic dermatitis
The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...
FDA Approves Lilly's EBGLYSSTM (Lebrikizumab-Lbkz) For Adults And Children 12 Years And Older With Moderate-To-Severe Atopic Dermatitis
Lilly has exclusive rights for development and commercialization of EBGLYSS in the U.S. and the rest of the world outside Europe. Lilly's partner Almirall S.A. has licensed the rights to develop and ...